RecruitingNot ApplicableNCT07334366

Broccoli Sprout Extract for Cognitive Function

A 12-week Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Broccoli Sprout Extract on Cognitive Function Improvement in Adults With Mild Cognitive Impairment


Sponsor

Pusan National University Yangsan Hospital

Enrollment

100 participants

Start Date

Apr 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial aims to determine whether broccoli sprout extract improves cognitive function in adults with mild cognitive impairment and to assess its safety. The main questions are: * Does broccoli sprout extract improve cognitive function in participants? * What side effects occur when participants take broccoli sprout extract?


Eligibility

Min Age: 50 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Broccoli sprout extract (BSE) and Placebo Control for people with cognitive decline and cognitive dysfunction. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTBroccoli sprout extract (BSE)

BSE 1,000 mg/day for 12 weeks

DIETARY_SUPPLEMENTPlacebo Control

Placebo (crystalline cellulosel) 1,000 mg/day for 12 weeks


Locations(1)

Pusan National University Yangsan Hospital

Yangsan, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07334366


Related Trials